Over-treatment of Renal Tumors: The Turtle in the Room - Robert G. Uzzo

(Length of discussion - 11 minutes)

Kidney cancer, like all cancers, has a spectrum of risk. There are groups of patients with incidentally detected asymptomatic, small renal masses that act relatively indolent and are often over-diagnosed and over-treated in some patients. The issue is defining who they are when they should or should not be treated.

Related Content:

Watch: Adjuvant Therapies for Renal Cell Carcinoma - Robert Uzzo

Perioperative Systemic Therapy for Kidney Cancer: Current Data and Ongoing Trials

Best of Journals: Renal Cell Carcinoma – Urologic Oncology - Session Highlights


Robert G. Uzzo, MD 

Chair, Department of Surgical Oncology

G. Willing "Wing" Pepper Chair in Cancer Research

Kidney, Bladder, and Prostate Cancer TRDG Member

Senior Vice-President, Physician Services

President, FCCC Medical Group, Inc.

Professor of Surgery, Temple University Health System

E. David Crawford 

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.